U.S. Healthcare Services Stock News

Advanced Micro Devices (AMD) stock is back in focus after the company settled its patent dispute with Adeia through a multi year licensing deal and rolled out new Ryzen AI chips for both desktop and embedded markets. See our latest analysis for Advanced Micro Devices. Even with the patent overhang cleared and fresh AI chips rolling out, AMD’s share price has seen a 30 day return of 5.17% decline and a 90 day return of 7.5% decline. By contrast, the 1 year total shareholder return of 103.22%...

Estée Lauder Companies (NYSE:EL) plans to acquire full ownership of Indian luxury skincare and beauty brand Forest Essentials. The transaction will transfer the remaining interests in Forest Essentials to Estée Lauder, deepening its presence in India’s premium beauty market. The deal builds on a long-running partnership between the two companies focused on Ayurveda inspired, wellness oriented products. For you as an investor following NYSE:EL, this move adds another established name to the...

Pangaea Logistics Solutions (PANL) just wrapped up FY 2025 with fourth quarter revenue of US$183.9 million and basic EPS of US$0.19, alongside net income of US$11.9 million, in a context where trailing twelve month revenue is US$632.0 million and EPS is US$0.30. Over recent periods, the company’s quarterly revenue moved from US$147.2 million in Q4 2024 to US$183.9 million in Q4 2025. Over the same quarters, basic EPS shifted from US$0.18 to US$0.19. Investors may weigh these changes in...

Recent share performance and business snapshot Without a single clear catalyst driving headlines today, PPG Industries (PPG) is drawing attention after a mixed run in its share price, including a decline over the past month alongside a modest gain over the past 3 months. The coatings group reports annual revenue of US$15.9b and net income of US$1.6b, with exposure across architectural, performance, and industrial coatings. This gives investors several different end markets to track when...

Earlier this month, Johnson & Johnson received U.S. FDA approval for TECVAYLI (teclistamab-cqyv) plus DARZALEX FASPRO for adults with relapsed or refractory multiple myeloma after at least one prior therapy, based on Phase 3 data showing substantially better disease control versus standard regimens. This combination, which pairs a BCMA-targeting bispecific with a subcutaneous anti-CD38 therapy, could materially expand Johnson & Johnson’s position in earlier-line multiple myeloma...

If you are wondering whether Realty Income is still fairly priced or starting to look appealing, you are not alone. This article focuses squarely on what you are getting for the current share price. The stock closed at US$64.71 most recently, with returns of 2.6% over the last 30 days and 21.3% over the past year, which may have shifted how the market views both its growth potential and risk. Recent headlines have focused on Realty Income's role as a large net lease REIT and its ongoing...

Tidewater Inc. has reported its fourth quarter and full-year 2025 results, with Q4 revenue of US$336.8 million and a sharp increase in net income to US$219.88 million, alongside full-year revenue of US$1.35 billion and net income of US$334.66 million. Alongside these results, the company issued 2026 revenue guidance of US$1.43–US$1.48 billion, signaling management’s expectations for higher activity levels across its offshore support operations. Now we’ll examine how Tidewater’s stronger 2025...

Circana, LLC recently announced a multiyear agreement with Sally Beauty Holdings to deploy a collaborative supply chain insights platform that delivers daily operational data to internal teams and suppliers, aiming to improve service levels, inventory management, and on-shelf availability across the retailer’s network. By giving suppliers shared, near real-time visibility into Sally Beauty’s inventory flows and promotion planning, the partnership is intended to tighten execution across the...

Arbor Realty Trust (ABR) is back in focus after reporting quarterly results that exceeded analyst revenue and EPS expectations, along with updates on nonperforming loans and continued activity under its share repurchase program. See our latest analysis for Arbor Realty Trust. At a share price of US$7.98, Arbor Realty Trust has seen a 1 day share price return of 1.40% and a 30 day share price return of 2.05%. However, its 1 year total shareholder return of 26.38% decline and 5 year total...

If you are wondering whether Insulet's current share price lines up with its underlying worth, or if the market is mispricing it, this article walks through that question step by step so you can form your own view. At a last close of US$238.82, Insulet's stock has seen a 1.7% decline over the past week, a 2.7% decline over the past month, and is down 15.6% year to date and 3.8% over the past year, with a 22.4% decline over three years and 8.1% decline over five years. These moves have put...

Kodiak AI (KDK) just wrapped up FY 2025 with Q4 revenue of US$1.1 million and a basic EPS loss of US$0.42. The trailing twelve months show revenue of US$16.5 million and a basic EPS loss of US$5.74. The company reported TTM revenue of US$14.9 million in FY 2024, alongside a basic EPS loss of US$0.79, giving investors a clearer view of how the top line and per share losses have been tracking into this latest result and providing context for the 6.5% revenue growth figure reported over the past...

Earnings beat puts Qorvo (QRVO) in focus Qorvo (QRVO) is back on investor radar after its latest earnings report, where revenue and earnings came in ahead of expectations, and all major segments contributed to year-on-year revenue growth. See our latest analysis for Qorvo. At a share price of US$78.63, Qorvo’s recent 30 day share price return of 5.45% decline and 90 day share price return of 12.06% decline contrast with a 1 year total shareholder return of 13.43%. This suggests longer term...

If you are wondering whether Science Applications International is attractively priced right now, you are not alone, especially with the stock sitting at US$91.60. The share price shows a 1.8% decline over the last 7 days, a 6.8% decline over 30 days, a 9.5% decline year to date and an 11.3% decline over 1 year. This contrasts with a modest 2.5% gain over 5 years and may be changing how investors think about its risk and return profile. Recent news coverage has focused on the company as a...

If you are wondering whether Cadence Design Systems is priced attractively today, you are not alone, and the numbers give a mixed first impression that is worth unpacking carefully. The stock last closed at US$294.16, with returns of 1.1% over 30 days, a 5.2% year to date decline, and 23.0% over 1 year, which can signal changing expectations around growth and risk. Recent coverage of Cadence has focused on its role in electronic design software and its positioning within semiconductor and AI...

Linde recently announced it will build, own, and operate a new air separation unit in Oshkosh, Wisconsin, to supply liquid oxygen, nitrogen, and argon to customers across Green Bay, Madison, Milwaukee, and Michigan’s Upper Peninsula, with land and equipment acquisition underway and plant startup targeted for the second half of 2028. This expansion adds fresh capacity to Linde’s U.S. industrial gas network, potentially deepening its role in serving manufacturing, healthcare, and other...

If you are wondering whether HubSpot's current share price reflects its long term potential, you are not alone. This article is built to help you frame that valuation question clearly. HubSpot last closed at US$259.10, with returns of 12.1% over 30 days, a 7.0% decline over 7 days, and longer term returns of 32.2% decline year to date and 57.6% decline over 1 year. Recent news around customer relationship management platforms and marketing automation tools has kept attention on companies...

ABM Industries (ABM) has reported Q1 2026 revenue of US$2.2 billion and basic EPS of US$0.64, with trailing twelve month EPS at US$2.55 on revenue of US$8.9 billion, highlighting a business that is currently generating steady top line and earnings power. Over the past few quarters the company has seen revenue move between US$2.1 billion and US$2.3 billion, while quarterly EPS has ranged from US$0.57 to US$0.70. This gives investors a clear view of how recent results fit within its recent...

In March 2026, Framatome announced it had expanded its long-running partnership with NuScale Power to use both its European facilities and the Richland, Washington plant to fabricate NRC-approved SMR fuel, including at least 444 fuel assemblies for NuScale’s first U.S. customer as early as 2030. This move effectively builds a transatlantic fuel supply chain around NuScale’s design, an important step toward turning early SMR interest in Europe and the U.S. into deliverable projects. Next,...

DexCom, Inc. recently announced that long-time leader Kevin R. Sayer has returned from a temporary leave to resume his role as Executive Chairman, while Rick Osterloh, a senior Google executive with deep consumer technology and AI experience, has joined the Board of Directors. These leadership moves strengthen DexCom’s board-level expertise in advanced hardware, software and artificial intelligence, potentially influencing how the company integrates digital health and consumer tech...

Nature's Sunshine Products (NATR) just wrapped up FY 2025 with Q4 revenue of US$123.8 million and basic EPS of US$0.23, while trailing twelve month revenue came in at US$480.1 million and EPS at US$1.08 as earnings for the period grew 153.7% and net margin reached 4.1%. The company has seen quarterly revenue move from US$118.2 million in Q4 2024 to US$123.8 million in Q4 2025, with basic EPS shifting from US$0.00 to US$0.23 over the same stretch. This sets up a story in which improved...

ProFrac Holding (ACDC) recently amended its credit agreement, trading lower maximum borrowing capacity and higher loan margins for an extended maturity to September 3, 2027. This change directly affects its funding profile. See our latest analysis for ProFrac Holding. The amended credit facility lands after a strong run in the share price, with a 45.05% year to date share price return and 30.80% 90 day share price return, even though the 1 year total shareholder return is a 21.97% decline and...

Why Arq’s halted GAC production matters for investors Arq (ARQ) has paused granular activated carbon production after independent testing highlighted equipment capacity limits. The company has idled its Corbin facility and recorded a non cash impairment charge tied to long lived assets in the fourth quarter of 2025. See our latest analysis for Arq. The halted GAC production, large non cash impairment and wider 2025 loss sit against a weak share price backdrop, with a 30 day share price return...

Compass stock performance snapshot Compass (COMP) has drawn investor attention after a month in which the share price declined about 33% and the past 3 months saw a decline of about 20%, prompting closer scrutiny of its fundamentals. See our latest analysis for Compass. The recent 1 month share price return of about 33% decline, combined with a 7 day share price return of about 9% decline, contrasts with a 3 year total shareholder return of about 191%. This indicates that shorter term...

Why Amkor Technology (AMKR) Is On Investors’ Radar Today Amkor Technology (AMKR) is in focus after recent trading saw the stock at a last close of $43.92, with returns mixed between the past week, month, and past 3 months. See our latest analysis for Amkor Technology. At a share price of $43.92, Amkor’s short term share price return has softened with a 30 day decline of 16.37%. However, its 1 year total shareholder return of 129.82% and 5 year total shareholder return of 98.70% still point to...